Latest Aswath Damodaran News | Aswath Damodaran News | Aswath Damodaran Funding | Aswath Damodaran Fund - vccircle
Advertisement

Aswath Damodaran

CPPIB doubles down on Paytm IPO with Rs1,280 cr bid

TMT

09 November, 2021

CPPIB doubles down on Paytm IPO with Rs1,280 cr bid

The Rs18,300 crore initial public offering (IPO) of Paytm’s parent company One97 Communications Ltd, the biggest such share sale to ......

Premium
Bidding war never good for the winner: Valuation guru Aswath Damodaran

Finance

23 April, 2018

Bidding war never good for the winner: Valuation guru Aswath Damodaran

India Inc has seen several bidding wars of late, as several potential buyers fight for companies in sectors such as ......

Facebook and Twitter: Hedging the bets

Others

20 February, 2016

Facebook and Twitter: Hedging the bets

I am not a big user of social media. I have a Facebook page, which I don’t visit often, never ......

Race to the top: The duel between Alphabet and Apple

Others

16 February, 2016

Race to the top: The duel between Alphabet and Apple

Apple and Alphabet, the two companies jockeying for the  prize of “largest market cap company in the world” are both ......

The compressed tech life cycle: the investor challenge

Others

22 December, 2015

The compressed tech life cycle: the investor challenge

Much of what we learn and practice as investors represent models and methods developed in a different age, one where ......

The compressed tech life cycle: the managerial challenge

Others

19 December, 2015

The compressed tech life cycle: the managerial challenge

In my last two posts, I first looked at Yahoo, in the context of the challenges associated with turning around ......

Aging in dog years? The short, glorious life of a successful tech company

Others

10 December, 2015

Aging in dog years? The short, glorious life of a successful tech company

The corporate aging theme is one that I have returned to repeatedly in my posts, and I have looked at ......

Divergence in the drug businesses: pharmaceuticals and biotechnology

Others

11 November, 2015

Divergence in the drug businesses: pharmaceuticals and biotechnology

In the last two weeks, I have started writing about , the epic fall of Valeant and the unraveling of ......

The ride sharing business: playing pundit

Others

22 October, 2015

The ride sharing business: playing pundit

This is the third and final post in a series of three on the ride sharing business. In the first, ......

Putting a price tag on scandal: sturm und drang at Volkswagen

General

02 October, 2015

Putting a price tag on scandal: sturm und drang at Volkswagen

My Vale missteps illuminated for me some of the risks of going where it is darkest, but I will not ......